LONDON (Dow Jones)--Biopharmaceutical company ReGen Therapeutics PLC (RGT.LN), said Friday it has conditionally placed 5 million new shares at 2 pence per share to raise GBP100,000, before expenses, for general working capital purposes. MAIN FACTS: -The new ordinary shares will represent 7.51% of the enlarged issued share capital of the company. -Shares at 0954 GMT unchanged at 2.4 pence, valuing the company at GBP1.5 million. -By Tapan Panchal, Dow Jones Newswires. Tel +44(0)207-842 9448, tapan.panchal@dowjones.com (END) Dow Jones Newswires June 25, 2010 05:57 ET (09:57 GMT)